| | Age ≤ 45 years | Age > 45 years |
---|
| | Odds ratio (95% CI)* | Odds ratio (95% CI)* |
---|
Genotype
|
1
| 1 | 1 |
|
2/3
| 1.42 (0.62-3.24) | 3.00 (1.65-5.47) |
- *adjusted for gender, nationality, route of infection, HCV-RNA, ALT, treating department (gastroenterology/hepatology vs. infectious diseases), treatment completion as scheduled, ended before scheduled or dose reduction